IBB iShares Nasdaq Biotechnology ETF

Seeks to track, before fees and expenses, the NASDAQ Biotechnology Index. The Index contains securities of NASDAQ-listed companies, including ADRs of non-US companies, classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria.

$116.38  +0.77 (0.67%)
As of 05/23/2022 15:59:55 EST     IEX book   CBOE book


ETF Information
Sponsor:     iShares
Category1:  US Equity
Category2:  Single industry
Category3:  Biotechnology
Morningstar category:  Health
Leverage factor:  1.00
Inception date:  02/05/2001
Index tracking method: Passive replication
Current yield:  0.27%
Historical average yield:  0.16%
Market cap:  $7,511,459,000
Average volume:  3,463,952
Fees:     0.4700%

Index Information
NASDAQ Biotechnology Index
Index symbol:  NBI
Provider:   NASDAQ OMX
Index weighting:   Market capitalization
Index inception date:  11/01/1993
Backtesting data exists:   No
Number of holdings:  159  (as of 11/28/2017)

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy